全球先進治療藥物市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，先進療法市場規模將從 2025 年的 672.1 億美元成長至 2,710.6 億美元，2026 年至 2034 年的複合年成長率為 16.76%。

受基因療法和細胞療法突破性進展的推動，全球先進治療藥物（ATMP）市場正經歷快速成長。先進治療藥物（ATMP）包括基因療法、細胞療法和組織工程產品。人們對罕見疾病和遺傳疾病治療日益成長的關注也推動了這一市場擴張。

關鍵成長要素包括對生物技術研究投入的增加和有利的法規結構。製藥公司正在加速推動創新治療方法的臨床試驗。個人化醫療方法的日益普及進一步刺激了需求。此外，生物技術公司與研究機構之間日益密切的合作也正在推動創新。

隨著更多先進治療藥物（ATMP）獲得監管部門核准並實現商業化，市場前景仍然強勁。新興市場正透過投資先進的醫療基礎設施創造成長機會。各公司正致力於可擴展的生產和成本最佳化。隨著再生醫學的進步，全球先進治療藥物市場預計將持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球先進治療藥物市場：依治療方法

• 市場分析、洞察與預測
• 細胞療法
• 基因治療
• 組織工程

第5章 全球先進治療藥物市場：依適應症分類

• 市場分析、洞察與預測
• 腫瘤學
• 神經病學
• 心臟病學
• 皮膚科
• 感染疾病
• 肌肉骨骼疾病
• 整形外科
• 其他（遺傳性疾病等）

第6章 全球先進治療藥物市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 其他（研究機構等）

第7章 全球先進治療藥物市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Spark Therapeutics Inc
  • Bluebird Bio Inc
  • Novartis AG
  • UniQure NV
  • Medipost
  • Vericel Corporation
  • Pharmicell Co. Ltd
  • Organogenesis Inc

The Advanced Therapy Medicinal Products Market size is expected to reach USD 271.06 Billion in 2034 from USD 67.21 Billion (2025) growing at a CAGR of 16.76% during 2026-2034.

The Global Advanced Therapy Medicinal Products Market is experiencing rapid growth driven by breakthroughs in gene and cell therapies. Advanced therapy medicinal products (ATMPs) include gene therapy, cell therapy, and tissue-engineered products. Increasing focus on treating rare and genetic diseases is supporting market expansion.

Major growth drivers include rising investment in biotechnology research and supportive regulatory frameworks. Pharmaceutical companies are accelerating clinical trials for innovative therapies. Growing adoption of personalized medicine approaches is further strengthening demand. Additionally, expanding collaborations between biotech firms and research institutions are fueling innovation.

Future prospects remain strong as more ATMPs receive regulatory approval and commercialization. Emerging markets investing in advanced healthcare infrastructure will create growth opportunities. Companies are focusing on scalable manufacturing and cost optimization. As regenerative medicine advances, the Global Advanced Therapy Medicinal Products Market is expected to witness sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy Type

• Cell Therapy
• Gene Therapy
• Tissue Engineering

By Indication

• Oncology
• Neurology
• Cardiology
• Dermatology
• Infectious Diseases
• Musculoskeletal Disorders
• Orthopedics
• Others (Genetic Disorders, etc.)

By End-user

• Hospitals
• Specialty Clinics
• Others (Research Institutes, etc.)

COMPANIES PROFILED

• Spark Therapeutics Inc, Bluebird Bio Inc, Novartis AG, UniQure NV, Medipost, Vericel Corporation, Pharmicell Co Ltd, Organogenesis Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy Type
• 4.2. Cell Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Tissue Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Musculoskeletal Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others (Genetic Disorders, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others (Research Institutes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Therapy Type
  • 7.2.2 By Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Therapy Type
  • 7.3.2 By Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Therapy Type
  • 7.4.2 By Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Therapy Type
  • 7.5.2 By Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Therapy Type
  • 7.6.2 By Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Spark Therapeutics Inc
  • 9.2.2 Bluebird Bio Inc
  • 9.2.3 Novartis AG
  • 9.2.4 UniQure N.V
  • 9.2.5 Medipost
  • 9.2.6 Vericel Corporation
  • 9.2.7 Pharmicell Co. Ltd
  • 9.2.8 Organogenesis Inc